发明名称 |
DRUG SELECTION FOR BREAST CANCER THERAPY USING ANTIBODY-BASED ARRAYS |
摘要 |
PROBLEM TO BE SOLVED: To provide compositions and methods for detecting activation states of components of signal transduction pathways in tumor cells.SOLUTION: The method includes incubating a cellular extract with a plurality of beads specific for an extracellular domain (ECD) binding region of a full-length receptor, and is used to detect presence of a truncated receptor, where the truncated receptor is p95ErbB2 and the full-length receptor is ErbB2 (HER-2). Information on the activation states of components of signal transduction pathways can be used for cancer diagnosis and prognosis and for designing cancer treatments. |
申请公布号 |
JP2013174616(A) |
申请公布日期 |
2013.09.05 |
申请号 |
JP20130102165 |
申请日期 |
2013.05.14 |
申请人 |
NESTEC SA |
发明人 |
SINGH SHARAT;JEANNE HARVEY;KIM PHILLIP;LIU XINJUN;LIU LIMIN;ROBERT BARHAM;BRUCE NERI |
分类号 |
G01N33/53;C12M1/34;C12Q1/26;C12Q1/54;G01N33/543;G01N37/00 |
主分类号 |
G01N33/53 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|